Digestive Diseases and Sciences

Impact of GLP-1 Analogue Therapy on Gastrointestinal Outcomes in Patients with Irritable Bowel Syndrome: A Real-World TriNetX Analysis

By Sajjad Ahmed Khan, Anurag Marasini, Alisha Shrestha, Dushyant Singh Dahiya

Cohort study of 6,665 peopleInterventions

The paper

Sajjad Ahmed Khan, Anurag Marasini, Alisha Shrestha, Dushyant Singh Dahiya

Birat Medical College Teaching Hospital; University of Kansas

Digestive Diseases and Sciences, 8 Aug 2026

doi.org/10.1007/s10620-026-10171-w PubMed 42570075

Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes, Obesity & Metabolism8 Oct 2026
Diabetes drug class linked to slightly less frailty progression
Drug Design, Development and Therapy5 Oct 2026
GLP-1 agonists linked to lower dementia risk after COVID-19